Patents
More
-
WASHINGTON, April 22- Apple Inc scored a win on Monday when the U.S. International Trade Commission ruled that it did not violate a Google patent to make the popular iPhones. The smartphone industry has seen dozens of lawsuits on several continents as Apple and companies that make smartphones that use Google's Android software vie for market share.
-
CAPE TOWN, April 22- South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior official said on Monday.
-
The Supreme Court will hear arguments in a case that calls into question whether DNA can be claimed as intellectual property, and remain off limits without the permission of the patent holder.
-
*Oral arguments begin Monday in Myriad Genetics patent suit. NEW YORK, April 14- Soon after learning that his son had autism, Hollywood producer Jon Shestack tried to get researchers investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes most likely to cause that disorder.
-
GENEVA, April 8- India's Trade Minister Anand Sharma said India would revoke drug patents if outbreaks of serious diseases or pandemics made it necessary, defending a Supreme Court ruling against Swiss drug firm Novartis.
-
WASHINGTON, April 5- Samsung Electronics Co Ltd infringed a key portion of an Apple Inc patent by including a text-selection feature in its smartphones and tablets, an International Trade Commission judge said in a preliminary decision.
-
LONDON/ MUMBAI, April 2- Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016..
-
MUMBAI/ NEW DELHI, April 1- India's top court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of cheap generics.
-
NEW DELHI, April 1- The Indian government hailed as "historic" a Supreme Court ruling on Monday against a plea by Swiss drugmaker Novartis AG to protect the patent on its drug Glivec.
-
MUMBAI, April 1- Novartis India Ltd, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the country's top court rejected its plea for patent protection of its drug Glivec.
-
NEW DELHI/ MUMBAI, April 1- India's top court rejected Swiss drugmaker Novartis AG's plea for patent protection of its cancer drug Glivec, a move likely to boost the prospects of Indian pharmaceutical firms over their foreign rivals.
-
India's top court has dealt a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.
-
NEW DELHI/ MUMBAI, April 1- India's top court has dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.
-
NEW DELHI, April 1- India's highest court has dismissed Swiss drugmaker Novartis AG's petition seeking patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms which are increasingly focusing on India to drive sales.
-
*Supreme Court decision on Novartis patent due April 1. India's Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country.
-
MUMBAI, March 27- Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their ability to sell lucrative patented medicines in the country.
-
Cloud-based service for remote device access announced a victory a in patent litigation case. CNBC's Josh Lipton reports the stock jumped on the news.
-
WASHINGTON, March 26- A federal appeals court aggressively questioned the scope of the public interest and trade secrets at a hearing on Tuesday over document secrecy in Apple Inc's patent litigation against Samsung Electronics Co Ltd..
-
AstraZeneca settled a patent dispute with generic drug maker Watson Laboratories over its cholesterol drug Crestor, reports CNBC's Bertha Coombs.
-
WASHINGTON, March 22- Microsoft Corp did not violate a patent owned by Google subsidiary Motorola Mobility when it made its popular Xbox, an administrative law judge at the International Trade Commission said in a preliminary decision issued on Friday.